Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice
Jennifer C. Wong, Stacey B. B. Dutton, Stephen D. Collins, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 137
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2018) Vol. 59, Iss. 10, pp. 1811-1841
Open Access | Times Cited: 119
Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
Jo Sourbron, Ilse Smolders, Peter de Witte, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 116
Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
Aliesha Griffin, Kyla R. Hamling, SoonGweon Hong, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 87
Recent Advances in the Drug Treatment of Dravet Syndrome
Elaine Wirrell, Rima Nabbout
CNS Drugs (2019) Vol. 33, Iss. 9, pp. 867-881
Closed Access | Times Cited: 82
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe
Elena Cardenal‐Muñoz, Stéphane Auvin, Vicente Villanueva, et al.
Epilepsia Open (2021) Vol. 7, Iss. 1, pp. 11-26
Open Access | Times Cited: 65
Huperzine A attenuates epileptic seizures via enhancing dCA1-projecting septal cholinergic transmission
Yu Wang, Ke-yu Hu, Qingyang Zhang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1
Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine
Soura Challal, Adrianna Skiba, Mélanie Langlois, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116740-116740
Closed Access | Times Cited: 17
Treatment Strategies for Dravet Syndrome
Kelly G. Knupp, Elaine Wirrell
CNS Drugs (2018) Vol. 32, Iss. 4, pp. 335-350
Closed Access | Times Cited: 51
Recent advances in treatment of epilepsy-related sodium channelopathies
Elisa Musto, Elena Gardella, Rikke S. Møller
European Journal of Paediatric Neurology (2019) Vol. 24, pp. 123-128
Closed Access | Times Cited: 51
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
Emanuele Micaglio, Emanuela H. Locati, Michelle M. Monasky, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant
Michelle M. Giddens, Jennifer C. Wong, Jason P. Schroeder, et al.
Neurobiology of Disease (2017) Vol. 106, pp. 181-190
Open Access | Times Cited: 42
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice
Lindsey Shapiro, Jennifer C. Wong, Andrew Escayg
Epilepsia (2019) Vol. 60, Iss. 12, pp. 2359-2369
Open Access | Times Cited: 39
Mice lacking full length Adgrb1 (Bai1) exhibit social deficits, increased seizure susceptibility, and altered brain development
Fu Hung Shiu, Jennifer C. Wong, Takahiro Yamamoto, et al.
Experimental Neurology (2022) Vol. 351, pp. 113994-113994
Open Access | Times Cited: 22
Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential
Sara Anjum Niinuma, Aiman D Khudair, Haniya Habib, et al.
Applied Materials Today (2024) Vol. 38, pp. 102197-102197
Closed Access | Times Cited: 4
Changing Landscape of Dravet Syndrome Management: An Overview
Debopam Samanta
Neuropediatrics (2020) Vol. 51, Iss. 02, pp. 135-145
Closed Access | Times Cited: 31
Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy
Jennifer C. Wong, Lindsey Shapiro, Jacquelyn T. Thelin, et al.
Neurobiology of Disease (2020) Vol. 147, pp. 105147-105147
Open Access | Times Cited: 28
Extended release huperzine for the treatment of idiopathic epilepsy in dogs – a Case Report
Ken Grant, Sam Long
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome
WeiHui Shao, Lu Liu, JiaXuan Gu, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
Lindsey Shapiro, Francesca Gado, Clementina Manera, et al.
Neuropharmacology (2021) Vol. 188, pp. 108448-108448
Open Access | Times Cited: 21
Enhancing the action of serotonin by three different mechanisms prevents spontaneous seizure‐induced mortality in Dravet mice
Jialing Guo, Daniel Min, Emory K. Farrell, et al.
Epilepsia (2024) Vol. 65, Iss. 6, pp. 1791-1800
Closed Access | Times Cited: 3
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg (GAERS) model of genetic generalized epilepsy with absence seizures
Pablo M. Casillas‐Espinosa, Jennie García‐Olivares, Rui Li, et al.
Epilepsia Open (2024) Vol. 9, Iss. 5, pp. 1826-1836
Open Access | Times Cited: 3
Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome
Jennifer C. Wong, Jacquelyn T. Thelin, Andrew Escayg
Annals of Clinical and Translational Neurology (2019) Vol. 6, Iss. 8, pp. 1566-1571
Open Access | Times Cited: 25
Generation and initial characterization of mice lacking full‐length BAI3 (ADGRB3) expression
Fu Hung Shiu, Jennifer C. Wong, Debanjan Bhattacharya, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 133, Iss. 4, pp. 353-363
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top